Cagent Vascular Stock

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.

Sign up today and learn more about Cagent Vascular Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cagent Vascular Stock

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease. Its commercialized angioplasty balloon with serration technology treats blocked arteries in the leg or peripheral artery disease and chronic limb-threatening ischemia.

Funding History

June 2016$500K
July 2018$11.9M
June 2021$9.5M
February 2024$30.0M

Management

Co-Founder, President & CEO

Carol A. Burns

Founder, CTO, and VP of Research and Development

Robert M. Giasolli

Chief Medical Officer, Co-Founder

Peter Schneider

COO

Peter Johansson

Advisor

Marianne Brodmann

Advisor

Llewellyn Lee

Chairman of the Board

Brian Walsh

Member Board of Directors

Dennis McGrath

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo